Amiodarone induced pulmonary toxicity: An unusual response to steroids

BACKGROUND: Amiodarone, class III anti-arrhythmic was originally introduced to treat angina pectoris, was later approved by FDA in 1985 for the treatment of ventricular arrhythmias. Despite its anti-arrhythmic properties, amiodarone is associated with side effects such as thyroid dysfunction, cornea...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Jalaj, Agrawal, Nikhil, Marballi, Abhishek, Agrawal, Sahil, Rawat, Naveen, Sule, Sachin, Lehrman, Stuart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615935/
https://www.ncbi.nlm.nih.gov/pubmed/23569490
http://dx.doi.org/10.12659/AJCR.882757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615935/
https://www.ncbi.nlm.nih.gov/pubmed/23569490
http://dx.doi.org/10.12659/AJCR.882757

Ejemplares similares